Search

Here is your summer issue of Cabot’s 10 Best Marijuana Stocks, with updates on the industry as a whole as well as all the important fundamental developments regarding the stocks in the portfolio.

In general, I remain very bullish on the marijuana sector long-term. I’m impressed by both the creativity demonstrated by the management of these companies, and the appetite for investment in the sector, by both individual investors and private equity. The future is bright.

The market had what amounted to a halfway decent eight-day rally, but the sellers pounced on that move, with most major indexes testing or reaching new correction lows today. From here, we’ll be watching to see how this short-term retest phase goes—given the very negative sentiment and obvious reason for the selling (tariffs), a super-powerful rally from here would be intriguing, especially if some resilient stocks (those that are holding well above their lows from a couple weeks ago) take flight. Over time, this decline will set the stage for a buoyant advance with lots of new leadership, but until that payoff arrives, continue to practice patience. As always, though, we just go with the here and now; we’ll yank our Market Monitor back down a notch to a level 3.

This week’s list is again very well rounded, though not surprisingly, there’s fewer go-go growth names, as more well-situated outfits are favored. Our Top Pick has both growth and defensive characteristics, and the stock is holding up very well.

The past month has brought great performances from many of our marijuana stocks, but right now, there’s a risk that the market is turning down, preparing to take some of our profits.

Long-term, however, trends toward increased legalization mean prospects for the marijuana sector are brighter than ever; next week’s election will tell us a lot about what the next few years might bring.



How do we balance this short-term risk with this long-term opportunity? By remaining invested in the best-performing stocks, of course.

Today’s stock candidate is a promising small-cap biotech with two high-potential drug candidates, each of which could develop into a billion-dollar asset.

Surprisingly good earnings reports boosted many stocks in our portfolios in recent weeks, and the same factor has turned the trends of the major indexes favorable; it’s good to be invested.
But we must never grow complacent, and one way I reduce risk in the Cabot Stock of the Week portfolio is by diversifying by both industry group and investment style.
This week’s recommendation, for example, is a growth stock; it was originally recommended by Mike Cintolo in Cabot Top Ten Trader. But it’s in an industry that’s generally regarded as conservative, and where stocks are usually appraised on a value basis. I think you’ll enjoy it.

While there are a lot of healthy signs of growth out there, stocks that do not meet high expectations are being punished.

Super Micro Computer (SMCI) was off 29% this past week after some allegations of faulty accounting by short sellers was followed by the company reporting yesterday that it was postponing filing of its annual report with the SEC to assess “internal controls over financial reporting.”

Given the uncertainty, we have little choice but to sell the stock. We took some profits earlier this year, and the stock is still up 43% so far this year. My guess is that we will be back to Super Micro at some point, and I will watch this stock carefully.

Last week, reviewing the 10 Revolutionary Stocks, I asked you which ones you owned.

Our emerging markets (EEM) signal continues to be positive and right on top of its 20-day moving average as China and other emerging markets are bumping along and lacking a decisive uptrend.

Here are five of my 10 top value stocks for 2017. All of my top value stocks are selling at bargain prices, and all have the potential to easily beat the stock market indexes in 2017!

This week’s update includes our comments on earnings from Walgreens Boots Alliance (WBA) and Wells Fargo & Company (WFC) as well as commentary on several stocks.

Royal Caribbean, Priceline.com and Winnebago are all Cabot Top Ten Weekly stocks.

Monthly dividend stocks are a perfect source of regular income you can use to pay bills, rent or buy groceries. Here are five to add to your portfolio.

After beating the market handily in 2017, our Wall Street’s Best experts are back with their top stock picks for 2018. Here are five of them.

Buying investment real estate is the best way to take advantage of the current housing boom. But there’s an easier way too.

The market hit an air pocket last week but has since stabilized. It didn’t hurt that revised U.S. GDP figures for Q4 came in 0.2% higher than previously reported. That improvement bumped growth up to 2.1%. On the back of that good news, small caps regained their 50-day moving average line (they’re now up four straight days).

In my mind, Warren Buffett is the best investor ever. Here are eight guidelines that will help you become a better investor.

The horrible second quarter is behind us and a rapidly recovering economy with a very accommodative Fed lies ahead. There are a lot of reasons for the rally and unless investors get scared straight the rally seems destined to continue.

There are no ratings changes today. My stance is cautiously optimistic, and favors resisting the temptation to chase stocks. Action is going to pick up next week as we have Blackbaud (BLKB), LogMeIn (LOGM) and Mitek (MITK) reporting. I’m expecting good things from all.

The market has been on edge since the Fed’s hawkish tone and updated Summary of Economic Projections (SEP) last week. But if we can get oil and interest rates to back off a little and some stock-specific catalysts during the upcoming Q3 earnings season maybe we can finally take our macroeconomist hats off and get back to doing what we’d rather do. Which is talk about some of the great small growth stories out there!